Sustained Release Oral Formulation For Treatment Of Parkinsons Disease
NCT07709741
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
Formulation A
DRUG:
Formulation B
DRUG:
Formulation C
Sponsor
University of Minnesota